Ade Odueyungbo, PhD

Senior Director
Dynavax Technologies
Emeryville, California, United States

Disclosure information not submitted.

Presentation(s):

• 411 - Phase 1/2 Trial of an Investigational Herpes Zoster Vaccine with CpG 1018® Adjuvant and Shingrix in Healthy Adults 50 to 69 Years of Age

  Tuesday, October 21, 2025
  2:45 PM - 2:57 PM US ET